PUMA BIOTECHNOLOGY, INC.
PBYI
15 insider filings · Latest: Sep 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Sep 17 1:13 AM | Troy Edward WilsonDirector | Sale | 5,000 | $9.10 | $45.5K | 54,750(D) | View → |
| Sep 14, 2026 | Sep 17 1:06 AM | Alessandra CesanoDirector | Sale | 62,150 | $9.12 | $567.0K | 56,700(D) | View → |
| Sep 14, 2026 | Sep 14 4:05 PM | Cesano Alessandra | Proposed Sale | 62,150 | $9.10 | $565.6K | — | View → |
| Sep 14, 2026 | Sep 14 4:01 PM | WILSON TROY EDWARD | Proposed Sale | 5,000 | $9.10 | $45.5K | — | View → |
| Jul 6, 2026 | Jul 9 12:21 AM | Alan H AuerbachDirector, President and CEO, 10% Owner | Sale | 44,058 | $8.26 | $364.1K | 7,261,671(D) | View → |
| Jul 6, 2026 | Jul 9 12:19 AM | Douglas M HuntThe Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | Sale | 8,460 | $8.26 | $69.9K | 196,841(D) | View → |
| Jul 6, 2026 | Jul 9 12:18 AM | Maximo F NouguesChief Financial Officer | Sale | 9,386 | $8.26 | $77.6K | 230,637(D) | View → |
| Jul 6, 2026 | Jul 6 8:56 PM | AUERBACH ALAN H | Proposed Sale | 44,058 | $8.26 | $364.0K | — | View → |
| Jul 6, 2026 | Jul 6 8:49 PM | HUNT DOUGLAS M | Proposed Sale | 8,460 | $8.26 | $69.9K | — | View → |
| Jul 6, 2026 | Jul 6 8:44 PM | NOUGUES MAXIMO F | Proposed Sale | 9,386 | $8.26 | $77.6K | — | View → |
| Jun 12, 2026 | Jun 16 12:16 AM | Troy Edward WilsonDirector | Sale | 10,800 | $7.20 | $77.7K | 59,750(D) | View → |
| Jun 12, 2026 | Jun 16 12:14 AM | Brian M StuglikDirector | Sale | 8,100 | $7.20 | $58.3K | 113,858(D) | View → |
| Jun 12, 2026 | Jun 16 12:13 AM | Adrian SenderowiczDirector | Sale | 27,000 | $7.20 | $194.3K | 27,000(D) | View → |
| Jun 12, 2026 | Jun 16 12:10 AM | Jay M MoyesDirector | Sale | 22,000 | $7.22 | $158.8K | 58,322(D) | View → |
| Jun 12, 2026 | Jun 16 12:09 AM | Allison DorvalDirector | Sale | 11,610 | $7.20 | $83.6K | 90,780(D) | View → |
| Jun 12, 2026 | Jun 12 2:39 PM | Senderowicz Adrian | Proposed Sale | 27,000 | $7.26 | $196.0K | — | View → |
| Jun 12, 2026 | Jun 12 2:37 PM | MOYES JAY M | Proposed Sale | 22,000 | $7.26 | $159.7K | — | View → |
| Jun 12, 2026 | Jun 12 2:33 PM | Dorval Allison | Proposed Sale | 11,610 | $7.26 | $84.3K | — | View → |
| Jun 12, 2026 | Jun 12 2:23 PM | Stuglik Brian M | Proposed Sale | 8,100 | $7.26 | $58.8K | — | View → |
| Jun 12, 2026 | Jun 12 1:58 PM | WILSON TROY EDWARD | Proposed Sale | 10,800 | $7.26 | $78.4K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Sep 17 1:06 AM | Alessandra CesanoDirector | Option Exercise | 50,000 | $2.93 | 50,000(D) | View → |
| Feb 18, 2026 | Feb 21 1:29 AM | Alan H AuerbachDirector, President and CEO, 10% Owner | Grant/Award | 227,474 | $6.68 | 227,474(D) | View → |
| Feb 18, 2026 | Feb 21 1:28 AM | Douglas M HuntThe Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | Grant/Award | 70,321 | $6.68 | 70,321(D) | View → |
| Feb 18, 2026 | Feb 21 1:28 AM | Maximo F NouguesChief Financial Officer | Grant/Award | 66,541 | $6.68 | 66,541(D) | View → |